Literature DB >> 6545412

The GH response to clonidine in endogenous as compared with reactive depression.

S A Checkley, I B Glass, C Thompson, T Corn, P Robinson.   

Abstract

The growth hormone (GH) response to clonidine was measured in 10 patients meeting standardized criteria for 'endogenous' depression and in 10 patients individually matched for age and sex but meeting the corresponding criteria for 'reactive' depression. In a paired comparison of patients with reactive and endogenous depression (matched for age and sex), the GH response to clonidine was less in the endogenous member of the pair in 8 out of 10 cases. These findings are interpreted as evidence of a defect at alpha 2 adrenoceptors in neuroendocrine systems in endogenous as compared with reactive depression.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6545412     DOI: 10.1017/s0033291700019747

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  5 in total

Review 1.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 3.  Can drugs cause depression? A review of the evidence.

Authors:  S B Patten; E J Love
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

4.  Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat.

Authors:  M Grealy; J M O'Donnell
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

5.  Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.

Authors:  L Lykouras; M Markianos; J Hatzimanolis; D Malliaras; C Stefanis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.